Paramvir Sidhu, M.D.

Paramvir Sidhu, M.D.

Research Division
  • MSRD
Programs

Biography

Dr. Sidhu is a board-certified rheumatologist with extensive experience in the study and management of rheumatic diseases. He currently serves as chief of Rheumatology and program director of the Rheumatology Fellowship at HonorHealth.

Dr. Sidhu completed his early schooling in the state of Punjab in north India. At age 18, he was selected to attend medical school at Punjab University’s Dayanand Medical College as part of meritorious students’ scholarship program. Dr. Sidhu moved to U.S. in 2004 to attend graduate school in public health at Loma Linda University, California.

In 2005, he started his internship in internal medicine at Weill Cornell Medicine/New York Hospital. During this time, he had the opportunity to work with many internationally renowned faculty at Memorial Sloan Kettering Cancer Center, Hospital for Special Surgery, The Rockefeller University and NYU Grossman School of Medicine. Dr. Sidhu moved to the University of Arizona in 2006 to finish his residency in internal medicine and further pursue training in Rheumatology under the mentorship of eminent rheumatologist and medical educator Dr. Eric Gall, finishing his Rheumatology Fellowship in 2011.

Dr. Sidhu serves on teaching service for HonorHealth Internal Medicine, Family Medicine, Dermatology & PMR residency programs and clinical professor of medicine at Arizona State University School of Medicine & Advanced Medical Engineering.

Dr. Sidhu also runs HonorHealth Bone Health Service that includes outpatient osteoporosis clinics, fracture liaison program, telehealth program and community-based osteoporosis education initiative as well as transition of care clinic for patients diagnosed with childhood metabolic bone diseases in partnership with endocrinology and orthopedic surgery.

Research Interests & Focus

During his time at the University of Arizona, Dr. Paramvir Sidhu worked on developing evidence-based protocols for early diagnosis and effective management of rheumatoid arthritis and psoriatic arthritis, using musculoskeletal ultrasound, and working with internationally acclaimed musculoskeletal radiologist Dr. Mihra Taljanovic and Professor Jeffery Lisse. This work was presented to the American College of Rheumatology Annual Meeting and to the American College of Rheumatology Annual Research Workshop, as well as later published in Arthritis & Rheumatology.
Dr. Sidhu also played a leading role at Clinical Research Unit (CRU) at the University of Arizona and the Arizona Arthritis Center as a clinical investigator on multiple clinical trials, primarily focused on use of B-cell blocking therapies in systemic lupus and IL-6 blockade in rheumatoid arthritis. He was part of pivotal clinical trials that led to approval of interleukin 6 inhibitor tocilizumab in rheumatoid arthritis and approval of BLyS inhibitor belimumab for management of systemic lupus.
Currently, Dr. Sidhu is focused on clinical trials in management of system lupus erythematosus (SLE), rheumatoid arthritis, psoriatic arthritis, systemic sclerosis and osteoporosis, as well as in development of innovative care delivery models including digital health platforms in management of rheumatic diseases.